Evidence map›Paper›PMID 31591383›Full record

ArticleCell death & disease2019

Progranulin attenuates liver fibrosis by downregulating the inflammatory response.

Wonbeak Yoo, Jaemin Lee, Kyung Hee Noh, Sangmin Lee, Dana Jung, Mohammad Humayun Kabir, Dongmin Park, Cheolju Lee, Ki-Sun Kwon, Ji-Su Kim and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Progranulin deficiency induces premature vascular senescence and dysfunction.American journal of physiology. Heart and circulatory physiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. 8-Methoxybicolosin C fromJournal of microbiology and biotechnology · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Wonbeak YooEnvironmental Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
Jaemin LeeIndustrial Bio-Materials Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
Kyung Hee NohKorea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
Sangmin LeeIndustrial Bio-Materials Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
Dana JungIndustrial Bio-Materials Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
Mohammad Humayun KabirCenter for Theragnosis, Korea Institute of Science and Technology, Seoul, 02792, Korea.
Dongmin ParkKorea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
Cheolju LeeCenter for Theragnosis, Korea Institute of Science and Technology, Seoul, 02792, Korea.ORCID http://orcid.org/0000-0001-8482-4696
Ki-Sun KwonAging Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Korea.
Ji-Su KimNational Primate Resources Center, Korea Research Institute of Bioscience and Biotechnology, Jeonbuk, 56212, Republic of Korea. kimjs@kribb.re.kr.
Seokho KimDepartment of Medicinal Biotechnology, College of Health Sciences, Dong-A University, Busan, 49315, Republic of Korea. cvaccine@dau.ac.kr.
Korea Research Institute of Bioscience and Biotechnology · KRDong-A University · KRKorea Institute of Science and Technology · KRStamford University Bangladesh · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progranulin (PGRN) is a cysteine-rich secreted protein expressed in endothelial cells, immune cells, neurons, and adipocytes. It was first identified for its growth factor-like properties, being implicated in tissue remodeling, development, inflammation, and protein homeostasis. However, these findings are controversial, and the role of PGRN in liver disease remains unknown. In the current study, we examined the effect of PGRN in two different models of chronic liver disease, methionine-choline-deficient diet (MCD)-induced non-alcoholic steatohepatitis (NASH) and carbon tetrachloride (CCl4)-induced liver fibrosis. To induce long-term expression of PGRN, PGRN-expressing adenovirus was delivered via injection into the tibialis anterior. In the CCl4-induced fibrosis model, PGRN showed protective effects against hepatic injury, inflammation, and fibrosis via inhibition of nuclear transcription factor kappa B (NF-κB) phosphorylation. PGRN also decreased lipid accumulation and inhibited pro-inflammatory cytokine production and fibrosis in the MCD-induced NASH model. In vitro treatment of primary macrophages and Raw 264.7 cells with conditioned media from hepatocytes pre-treated with PGRN prior to stimulation with tumor necrosis factor (TNF)-α or palmitate decreased their expression of pro-inflammatory genes. Furthermore, PGRN suppressed inflammatory and fibrotic gene expression in a cell culture model of hepatocyte injury and primary stellate cell activation. These observations increase our understanding of the role of PGRN in liver injury and suggest PGRN delivery as a potential therapeutic strategy in chronic inflammatory liver disease.

Indexed as

AnimalsEndothelial CellsGene Expression RegulationHepatic Stellate CellsHepatocytesHumansInflammationLiverLiver CirrhosisMiceNF-kappa BNon-alcoholic Fatty Liver DiseaseProgranulinsRAW 264.7 CellsNF-kappa BProgranulins

Identifiers

PMID31591383
PMCPMC6779917
OpenAlexW2978238672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.